Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$9,953,084
+$100,686 QoQ
Shares Held
39,190
-2.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
3.54%
of 13F equity value
Holder Rank
#1,116
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BURKE & HERBERT BANK & TRUST CO holds $27,845,338 across 9 Drug Manufacturers - General names. JNJ ranks #1 (35.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
39,190 | $9,953,084 | |
| 2 | LLY |
ELI LILLY & Co
|
5,231 | $6,274,217 | |
| 3 | ABBV |
AbbVie Inc.
|
20,061 | $5,048,149 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,309 | $2,609,706 | |
| 5 | PFE |
Pfizer Inc
|
67,288 | $1,620,294 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
13,041 | $751,422 | |
| 7 | NVS |
Novartis AG
|
3,847 | $602,901 | |
| 8 | AMGN |
Amgen Inc
|
1,593 | $576,856 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,953,084 | 39,190 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $9,852,398 | 40,306 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $8,284,414 | 40,031 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $9,359,999 | 50,480 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $7,825,229 | 51,229 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $8,505,103 | 51,285 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $7,471,066 | 51,660 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $8,394,381 | 51,798 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $7,758,757 | 53,084 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $2,682,427 | 16,957 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $3,582,292 | 22,855 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $3,568,076 | 22,909 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $4,646,642 | 28,073 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $5,558,300 | 35,860 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $6,359,399 | 36,000 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $5,949,570 | 36,420 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,480,889 | 36,510 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $6,579,486 | 37,124 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $6,451,562 | 37,713 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $6,250,534 | 38,703 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $6,385,981 | 38,764 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $6,376,450 | 38,798 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $6,108,703 | 38,815 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $5,900,858 | 39,635 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $5,545,743 | 39,435 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $5,227,365 | 39,864 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||